Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP): Clinical Colorectal Cancer

Rachel P. Riechelmann, Vichien Srimuninnimit, Roberto Bordonaro, Petr Kavan, Maria Di Bartolomeo, Evaristo Maiello, Irfan Cicin, Pilar García-Alfonso, Ian Chau, Mikhail Y. Fedyanin, Carlos Fernández Martos, Mikhail Ter-Ovanesov, Marc Peeters, Yoo-Joung Ko, Suayib Yalcin, Meinolf Karthaus, Jorge Aparicio, Volker Heinemann, Pascaline Picard, Denise BuryEdward Drea, Alberto Sobrero

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP): Clinical Colorectal Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences